251 related articles for article (PubMed ID: 26265447)
1. Multicentre randomized clinical trial to investigate the cost-effectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study).
Tavilla G; Bruggemans EF; Gielen CL; Brand A; van den Hout WB; Klautz RJ; van Hilten JA
Br J Surg; 2015 Oct; 102(11):1338-47. PubMed ID: 26265447
[TBL] [Abstract][Full Text] [Related]
2. Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study.
Massin P; Scemama C; Jeanrot C; Boyer P
Orthop Traumatol Surg Res; 2012 Apr; 98(2):180-5. PubMed ID: 22405589
[TBL] [Abstract][Full Text] [Related]
3. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.
Carless PA; Henry DA; Anthony DM
Cochrane Database Syst Rev; 2003; 2003(2):CD004171. PubMed ID: 12804501
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Cell salvage during coronary artery bypass surgery and allogenic blood exposure.
Al-Mandhari S; Maddali MM; Al-Bahrani MJ
Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):913-6. PubMed ID: 26113735
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.
Lowe J; Luber J; Levitsky S; Hantak E; Montgomery J; Schiestl N; Schofield N; Marra S;
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):323-31. PubMed ID: 17505437
[TBL] [Abstract][Full Text] [Related]
7. The use fibrinogen/thrombin-coated equine collagen patch in children requiring reoperations for congenital heart disease. A single center clinical experience.
Vida VL; De Franceschi M; Barzon E; Padalino MA; Scattolin F; Stellin G
J Cardiovasc Surg (Torino); 2014 Jun; 55(3):401-6. PubMed ID: 24755705
[TBL] [Abstract][Full Text] [Related]
8. Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial.
Codispoti M; Mankad PS
Eur J Cardiothorac Surg; 2002 Aug; 22(2):200-5. PubMed ID: 12142185
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures.
Chalmers RT; Darling Iii RC; Wingard JT; Chetter I; Cutler B; Kern JA; Hart JC
Br J Surg; 2010 Dec; 97(12):1784-9. PubMed ID: 20730858
[TBL] [Abstract][Full Text] [Related]
10. [Medical and economic impact of a haemostatic sealant on the rate of transfusion after total knee arthroplasty].
Choufani C; Barbier O; Bajard X; Ollat D; Versier G
Transfus Clin Biol; 2015 Mar; 22(1):22-9. PubMed ID: 25684620
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion.
Carless PA; Anthony DM; Henry DA
Br J Surg; 2002 Jun; 89(6):695-703. PubMed ID: 12027978
[TBL] [Abstract][Full Text] [Related]
12. Fibrin sealant provides superior hemostasis for sternotomy compared with bone wax.
Yu L; Gu T; Song L; Shi E; Fang Q; Wang C; Zhao J
Ann Thorac Surg; 2012 Feb; 93(2):641-4. PubMed ID: 22269729
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery.
Alström U; Levin LÅ; Ståhle E; Svedjeholm R; Friberg O
Br J Anaesth; 2012 Feb; 108(2):216-22. PubMed ID: 22113929
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts.
Saha SP; Muluk S; Schenk W; Dennis JW; Ploder B; Grigorian A; Presch I; Goppelt A
J Vasc Surg; 2012 Jul; 56(1):134-41. PubMed ID: 22633423
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery.
Covin R; O'Brien M; Grunwald G; Brimhall B; Sethi G; Walczak S; Reiquam W; Rajagopalan C; Shroyer AL
Arch Pathol Lab Med; 2003 Apr; 127(4):415-23. PubMed ID: 12683868
[TBL] [Abstract][Full Text] [Related]
18. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
[TBL] [Abstract][Full Text] [Related]
19. Determination of the efficacy of EVICEL™ on blood loss in orthopaedic surgery after total knee replacement: study protocol for a randomised controlled trial.
Budde S; Noll Y; Zieglschmid V; Schroeder C; Koch A; Windhagen H
Trials; 2015 Jul; 16():299. PubMed ID: 26162825
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
